Correlation Between Henry Schein and Sinopharm Group
Can any of the company-specific risk be diversified away by investing in both Henry Schein and Sinopharm Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Henry Schein and Sinopharm Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Henry Schein and Sinopharm Group Co, you can compare the effects of market volatilities on Henry Schein and Sinopharm Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Henry Schein with a short position of Sinopharm Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Henry Schein and Sinopharm Group.
Diversification Opportunities for Henry Schein and Sinopharm Group
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Henry and Sinopharm is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Henry Schein and Sinopharm Group Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinopharm Group and Henry Schein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Henry Schein are associated (or correlated) with Sinopharm Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinopharm Group has no effect on the direction of Henry Schein i.e., Henry Schein and Sinopharm Group go up and down completely randomly.
Pair Corralation between Henry Schein and Sinopharm Group
Assuming the 90 days horizon Henry Schein is expected to generate 6.39 times less return on investment than Sinopharm Group. But when comparing it to its historical volatility, Henry Schein is 1.43 times less risky than Sinopharm Group. It trades about 0.04 of its potential returns per unit of risk. Sinopharm Group Co is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 197.00 in Sinopharm Group Co on September 23, 2024 and sell it today you would earn a total of 67.00 from holding Sinopharm Group Co or generate 34.01% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Henry Schein vs. Sinopharm Group Co
Performance |
Timeline |
Henry Schein |
Sinopharm Group |
Henry Schein and Sinopharm Group Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Henry Schein and Sinopharm Group
The main advantage of trading using opposite Henry Schein and Sinopharm Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Henry Schein position performs unexpectedly, Sinopharm Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinopharm Group will offset losses from the drop in Sinopharm Group's long position.Henry Schein vs. AmerisourceBergen | Henry Schein vs. Cardinal Health | Henry Schein vs. Shanghai Pharmaceuticals Holding | Henry Schein vs. Sinopharm Group Co |
Sinopharm Group vs. AmerisourceBergen | Sinopharm Group vs. Cardinal Health | Sinopharm Group vs. Henry Schein | Sinopharm Group vs. Shanghai Pharmaceuticals Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |